The phosphatase and tensin homologue (PTEN) promoter is a natural inhibitor of PI3K/AKT pathway, and studies have shown that targeting PPARs can induce tumour regression by inducing PTEN expression. The gene discussed is AKT1; the disease is neoplasm.